Dhoundiyal S, Alam M
Curr Stem Cell Res Ther. 2023; 19(8):1072-1083.
PMID: 37815191
DOI: 10.2174/011574888X268109230924233850.
Dyan B, Seele P, Skepu A, Mdluli P, Mosebi S, Sibuyi N
Diagnostics (Basel). 2022; 12(8).
PMID: 36010323
PMC: 9406634.
DOI: 10.3390/diagnostics12081973.
Jin M, Cao W, Chen B, Xiong M, Cao G
Front Cell Dev Biol. 2022; 10:808859.
PMID: 35646923
PMC: 9136137.
DOI: 10.3389/fcell.2022.808859.
Cao W, Jin M, Yang K, Chen B, Xiong M, Li X
J Nanobiotechnology. 2021; 19(1):325.
PMID: 34656118
PMC: 8520258.
DOI: 10.1186/s12951-021-01074-1.
Tutunchi S, Akhavan S, Bereimipour A, Ghaderian S
J Oncol. 2021; 2021:5571413.
PMID: 34054953
PMC: 8131151.
DOI: 10.1155/2021/5571413.
Robotic DNA Nanostructures.
Nummelin S, Shen B, Piskunen P, Liu Q, Kostiainen M, Linko V
ACS Synth Biol. 2020; 9(8):1923-1940.
PMID: 32589832
PMC: 7467825.
DOI: 10.1021/acssynbio.0c00235.
Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.
Gao X, Mi Y, Guo N, Xu H, Xu L, Gou X
Front Immunol. 2017; 8:774.
PMID: 28729866
PMC: 5498561.
DOI: 10.3389/fimmu.2017.00774.
Designer nanoparticle: nanobiotechnology tool for cell biology.
Thimiri Govinda Raj D, Khan N
Nano Converg. 2017; 3(1):22.
PMID: 28191432
PMC: 5271163.
DOI: 10.1186/s40580-016-0082-x.
The Zn(II) nanocomplex: Sonochemical synthesis, characterization, DNA- and BSA-binding, cell imaging, and cytotoxicity against the human carcinoma cell lines.
Anjomshoa M, Torkzadeh-Mahani M, Shakeri M, Adeli-Sardou M
J Fluoresc. 2016; 26(3):1007-20.
PMID: 26987745
DOI: 10.1007/s10895-016-1788-1.
Convergence Science Arrives: How Does It Relate to Psychiatry?.
Eyre H, Lavretsky H, Forbes M, Raji C, Small G, McGorry P
Acad Psychiatry. 2016; 41(1):91-99.
PMID: 26964782
PMC: 5540327.
DOI: 10.1007/s40596-016-0496-0.
Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use.
Spindel S, Sapsford K
Sensors (Basel). 2014; 14(12):22313-41.
PMID: 25429414
PMC: 4299016.
DOI: 10.3390/s141222313.
Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.
Hauert S, Bhatia S
Trends Biotechnol. 2014; 32(9):448-55.
PMID: 25086728
PMC: 4295824.
DOI: 10.1016/j.tibtech.2014.06.010.
Robust microarray meta-analysis identifies differentially expressed genes for clinical prediction.
Phan J, Young A, Wang M
ScientificWorldJournal. 2013; 2012:989637.
PMID: 23365541
PMC: 3539384.
DOI: 10.1100/2012/989637.
Multiscale integration of -omic, imaging, and clinical data in biomedical informatics.
Phan J, Quo C, Cheng C, Wang M
IEEE Rev Biomed Eng. 2012; 5:74-87.
PMID: 23231990
PMC: 5859561.
DOI: 10.1109/RBME.2012.2212427.
Personalized medicine in breast cancer: a systematic review.
Cho S, Jeon J, Kim S
J Breast Cancer. 2012; 15(3):265-72.
PMID: 23091538
PMC: 3468779.
DOI: 10.4048/jbc.2012.15.3.265.
omniBiomarker: A Web-Based Application for Knowledge-Driven Biomarker Identification.
Phan J, Young A, Wang M
IEEE Trans Biomed Eng. 2012; 60(12):3364-7.
PMID: 22893372
PMC: 5003093.
DOI: 10.1109/TBME.2012.2212438.
Nanoinformatics: a new area of research in nanomedicine.
Maojo V, Fritts M, de la Iglesia D, Cachau R, Garcia-Remesal M, Mitchell J
Int J Nanomedicine. 2012; 7:3867-90.
PMID: 22866003
PMC: 3410693.
DOI: 10.2147/IJN.S24582.
Reverse engineering biomolecular systems using -omic data: challenges, progress and opportunities.
Quo C, Kaddi C, Phan J, Zollanvari A, Xu M, Wang M
Brief Bioinform. 2012; 13(4):430-45.
PMID: 22833495
PMC: 3404400.
DOI: 10.1093/bib/bbs026.
Cardiovascular genomics: a biomarker identification pipeline.
Phan J, Quo C, Wang M
IEEE Trans Inf Technol Biomed. 2012; 16(5):809-22.
PMID: 22614726
PMC: 5003026.
DOI: 10.1109/TITB.2012.2199570.
Multiplexed detection and characterization of rare tumor cells in Hodgkin's lymphoma with multicolor quantum dots.
Liu J, Lau S, Varma V, Kairdolf B, Nie S
Anal Chem. 2010; 82(14):6237-43.
PMID: 20565106
PMC: 2914471.
DOI: 10.1021/ac101065b.